Morgan Stanley Q3 Preview: Another Weak Quarter, but Move to Sidelines Ahead of Vaccine/Elections
NATIONAL REPORT—Morgan Stanley & Co. expects relatively weak third-quarter results and tempered commentary, but as a COVID vaccine and elections approach, the company’s strategists
Read More